Research Reports

U Y Fincorp Q1 FY27: standalone PAT up 229% YoY to ₹19.6 Cr as lending income scales 6x

nbfc · interest income growth · lending book expansion

AstraZeneca India Q1 standalone PAT falls 32% YoY to ₹37.9 Cr as margins compress

pharma · margin compression · pat decline

Talbros Q1FY27: consol PAT +35% YoY to ₹30 Cr on JV boost; margin trails 17-18% guide

auto components · jv profit contribution · margin compression

Indo Borax Q1 FY27: consolidated PAT jumps 59% YoY to ₹16.3 Cr, margins expand further

boron chemicals · margin expansion · revenue growth

Record Revenue, Margin Collapse — What 52% Growth Really Means

organic growth · alloy pass-through · margin compression

Record growth, margin recovery awaited amid commodity normalization

capacity expansion · high-teens growth · alloy wheel ramp

SPARC Q1 loss narrows to ₹20.8 Cr YoY, but the gain is a one-off licensing fee

pharma r&d · one-off revenue · licensing termination

KPR Mill Q1FY27: PAT Beats Street at ₹259 Cr (+21% YoY) on Sugar Segment Turnaround

textiles · sugar segment · margin expansion

Jain Irrigation swings to ₹17.8 Cr loss as core agri segment revenue drops 22% YoY

irrigation · agri input · margin compression

Hindustan Copper consolidated PAT jumps 162% YoY to ₹352 Cr as margins expand; -21% QoQ

copper · psu miner · margin expansion

Info Edge Q1FY27: strong operating momentum, but one-offs drive consolidated PAT +43%

recruitment · naukri · billings growth

MSAFE Q1 FY27: standalone PAT up 44% YoY to ₹7.27 Cr as EBITDA margin expands to ~42%

scaffolding · aluminium formwork · sme ipo

Astra Micr owave Q1 FY27: consol. PAT down 24% YoY, revenue -11.5% as margins compress

defense electronics · revenue decline · margin compression

M&B Engineering Q1FY27: consolidated PAT +22% YoY to ₹22 Cr, margins compress as guided

pre-engineered buildings · margin compression · export growth

The ₹9-Crore Quarter: Restructuring Win Clouded by FX Gain and Beryl Drag

margin expansion · automation · Beryl integration

Lyka Labs Q1 FY27: consolidated PAT doubles YoY to ₹2.05 Cr as revenue rises 28%

pharmaceuticals · subsidiary divestment · revenue growth

Margins soar on restructuring; Beryl drag near-term, civil strength lingers

margin expansion · automation · Beryl profitability

Kwality Pharma Q1FY27: consolidated PAT surges 115% YoY to ₹25.6 Cr, margins expand, guidance raised

pharma exports · margin expansion · guidance raise

Ramco Industries Q1FY27: consol. PAT +32% YoY (~22% adjusted) as OPM jumps to 16%

fibre cement · building products · margin expansion

Defence Consolidation Meets the Navy's Confidence: Apollo Micro's Strategic Inflection

Defence manufacturing · M&A consolidation · Indigenous innovation

Q1 FY27: Revenue +26% YoY but PAT -9% as operating margin crashes to 0.3%

margin compression · operating margin · material costs

Gland Pharma's $90–100M CDMO Prize: When a Pharma Contract Becomes a Business

CDMO · sterile injectables · contract manufacturing

Garuda Construction: PAT jumps 48% YoY, revenue up 40% as margins expand in Q1 FY27

construction · margin expansion · revenue growth

The $150 Million Inflection: Blue Cloud Validates AI Infrastructure as a Strategic Moat

AI infrastructure · space tech · datacenter

When Order Books Trump Growth Rates: Quality Power's Manufacturing Inflection

First Public Quarter: Expansion Execution & Valuation Under Scrutiny

metal recycling · secondary aluminium · IPO premium

Margin Test Ahead: Defence Orders Steady, Cost Inflation in Focus

defence sector · superalloys · margin compression

Defense tailwinds and aerospace scale—but margins remain under scrutiny

defense orders · BrahMos · Airbus

Dividend Momentum & Stability Test — Can BENGALASM Sustain ₹501 Payout Amid Market Headwinds?

dividend yield · financial services · management transition

Can H.G. Infra prove execution after Q4 collapse and MSRDC shock? Q1 is the credibility test

infrastructure · highways · power transmission